Corindus Vascular Robotics has declared the outcome of the first-in-human clinical study its CorPath 200 robotic system, which was conducted at the Corbic Research Institute, Colombia.
Based on a research, the American Society of Health-System Pharmacists has revealed that in the nation, only 24% of hospitals adopt the bar coding method of validating the medications which are delivered by the pharmacy.
Stereotaxis, Inc. has declared that it has obtained its 100th patent from the U.S. Patent and Trademark Office for "Method and Apparatus for Dynamic Magnetic Field Control Using Multiple Magnets."
Automated Systems of Tacoma (AST) has created a new vision guided robot for a client industry involved in life research in order to automate the filling up of their trial medications in different container formats including syringes, vials, cartridges and IV bags.
Dr. Mahesh Ramchandani, a cardiovascular and thoracic surgeon, at the Methodist DeBakey Heart & Vascular Center, Houston, has been reported to utilize C-Port distal anastomosis and PAS-Port proximal anastomosis systems of Cardica Inc, in the minimally-invasive cardiac surgery/coronary artery bypass graft (MICS CABG) surgery, thereby providing an effective alternate procedure to the conventional open chest bypass graft.
Accuray Incorporated, a manufacturer of the CyberKnife robotic radiosurgery system, has declared that Euan S. Thomson, President and CEO of the company will participate in the UBS Global Life Sciences Conference, New York on September 21 2010 at 2:00 p.m.
ScriptPro, a provider of robotics-based systems for pharmacies, has been selected by the National Institutes of Health (NIH) for implementing ScriptPro’s various pharmacy automation systems including robotic dispensing, drug information and pharmacy automation systems in the NIH.
Frost & Sullivan has identified the profound pharmacy automation services of Swisslog Healthcare Solutions and has declared it as the recipient of "2010 Best Practices Award".
BIOTRONIK, a leading provider of implantable cardiac devices (ICD) and other sophisticated remote monitoring solutions, has declared that the outcome of the TRUST Trial (Lumax-T/Lumos-T Safely Reduces Routine Office Device Follow-up) have been made available online.
Dr. David B. Samadi, Chief, Division of Robotics and Minimal Invasive Surgery at Mount Sinai School of Medicine, has reported that the most frequently identified cancer is Prostate cancer and at present it is the second major reason of cancer deaths in the US.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.